Recurrent Respiratory Papillomatosis and Extraesophageal Reflux

Sponsor
University Hospital Ostrava (Other)
Overall Status
Completed
CT.gov ID
NCT02592902
Collaborator
(none)
60
1
2
53
1.1

Study Details

Study Description

Brief Summary

The purpose of the study was to determine, whether patients with recurrent respiratory papillomatosis (RRP) suffer from extra oesophageal reflux more often than patients with laryngeal cyst (control group).

Condition or Disease Intervention/Treatment Phase
  • Procedure: Surgical collection of histology specimen
  • Procedure: Performance of immunohistochemical analysis
N/A

Detailed Description

Recurrent respiratory papillomatosis (RRP) is a chronic viral disease, which affects children and adults as well. It is characterised by grow of squamous cell tumours on mucosa of aerodigestive tract, with predilection for the larynx. The disease is caused by the human papillomavirus (HPV). However, in contrast to the low incidence of RRP, HPV prevalence is common. It is indicated that other factors may contribute to the pathogenesis of RRP. One such factor might be extraesophageal reflux (EER). We investigated whether patients with RRP suffer more often from EER.

Study Design

Study Type:
Interventional
Actual Enrollment :
60 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Recurrent Respiratory Papillomatosis and Extraesophageal Reflux
Study Start Date :
Apr 1, 2014
Actual Primary Completion Date :
Aug 1, 2018
Actual Study Completion Date :
Sep 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Recurrent respiratory papillomatosis

Patients with recurrent respiratory papillomatosis (RRP) - surgical collection of histology specimen from the vocal cords and rear laryngeal commissure, performance of immunohistochemical analysis - proof of pepsin, HPV 6 and 11, herpes simplex virus (HSV) type 2, chlamydia trachomasis, and assessment of the dysplasia.

Procedure: Surgical collection of histology specimen
Collection of a histology specimen from the vocal cords and rear laryngeal commissure

Procedure: Performance of immunohistochemical analysis
Immunohistochemical analysis - presence of pepsin, HPV 6 and 11, HSV 2 and chlamydia trachomasis

Active Comparator: Laryngeal cyst - control group

Patients with laryngeal cyst - surgical collection of a histology specimen from the vocal cords and rear laryngeal commissure, performance of immunohistochemical analysis - proof of pepsin and HPV 6 and 11, herpes simplex virus (HSV) type 2 and chlamydia trachomasis.

Procedure: Surgical collection of histology specimen
Collection of a histology specimen from the vocal cords and rear laryngeal commissure

Procedure: Performance of immunohistochemical analysis
Immunohistochemical analysis - presence of pepsin, HPV 6 and 11, HSV 2 and chlamydia trachomasis

Outcome Measures

Primary Outcome Measures

  1. Occurrence of EER (percentage) [36 months]

    The occurrence of extra oesophageal reflux will be assessed in both study groups.

Secondary Outcome Measures

  1. Presence of pepsin [36 months]

    The presence of pepsin (yes-no) will be assessed in both study groups.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age 1-75 years

  • cooperating patients with laryngeal papillomatosis

  • patients tolerating impedance probe

  • signed informed consent, consent with the examinations

  • control group of patients with a cyst or vocal cord polyp (reflux finding score 0-2) and/or patients indicated to augmentation, medialization or lateralization of the vocal cords

Exclusion Criteria:
  • patients non-tolerating impedance catheter

  • patients who do not understand Czech language

  • patients who do not proclaim consent with enrolment into the study

  • patients who do not proclaim consent with the planned examinations

  • patients after surgical treatment of tumour of the swallowing or respiratory tract

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Hospital Ostrava Ostrava-Poruba Czech Republic Czechia 708 52

Sponsors and Collaborators

  • University Hospital Ostrava

Investigators

  • Principal Investigator: Martin Formanek, MD, University Hospital Ostrava

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
University Hospital Ostrava
ClinicalTrials.gov Identifier:
NCT02592902
Other Study ID Numbers:
  • FNO-ENT-papilomatosis
First Posted:
Oct 30, 2015
Last Update Posted:
Feb 20, 2019
Last Verified:
Feb 1, 2019

Study Results

No Results Posted as of Feb 20, 2019